Article
Identification of a novel interaction of FUS and syntaphilin may explain synaptic and mitochondrial abnormalities caused by ALS mutations.
Scientific reports - 30 Jun 2021
Salam Shaakir, Tacconelli Sara, Smith Bradley N, Mitchell Jacqueline C, Glennon Elizabeth, Nikolaou Nikolas, Houart Corinne, Vance Caroline
Abstract excerpt
Aberrantly expressed fused in sarcoma (FUS) is a hallmark of FUS-related amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Wildtype FUS localises to synapses and interacts with mitochondrial proteins while mutations have been shown to cause to pathological changes affecting mitochondria, synapses and the neuromuscular junction (NMJ). This indicates a crucial physiological role for FUS in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
